Human Studies on MS Screening and Neurorehabilitation
Research shows that multidimensional screening for multiple sclerosis (MS) should include functional limitations and social determinants of health, rather than just symptom severity. Technologies like wearables and remote monitoring could enhance evaluations, and early neurorehabilitation is recommended. However, diverse interventions have benefits, but gaps in implementation and access remain.
- Tags
- #MSResearch
- Most relevant to
- —
- Human efficacy
- Not applicable – no treatment tested
- Mechanism
- Not reported
- Evidence strength
- Moderate
- Outcome
- Not reported
Why it matters
This research highlights the need for comprehensive evaluation strategies and early intervention for MS, aiming to improve overall quality of life for patients. Identifying barriers may help optimize rehabilitation outcomes across varied populations.
What this does not prove
There remain significant research gaps in screening implementation, treatment matching, and equitable access to services for diverse populations. This limits our understanding of how best to apply these findings in real-world settings.
Next milestone
No next milestone was established from the available source.
Study facts
- Study design
- Systematic review
- Participants / samples
- Not reported
- Randomised
- Not reported
- Controlled
- Not reported
- Primary endpoint met
- Not reported
- Relevant MS type
- Not reported
- Publication date
- 2026-10-27
- Evidence reviewed
- Abstract only
- Regulatory approval
- Not reported
- Research areas
- Not classified
- Biological target
- Not reported
- Pathway
- Not reported
- Population
- Not reported
- Size of effect
- Not reported
- Secondary endpoints
- Not reported
- MRI endpoints
- Not reported
- Biomarkers
- Not reported
- Safety
- Not reported
Original sources
- Primary evidenceRecent advances in multiple sclerosis neurorehabilitation. ↗DOI: 10.1097/wco.0000000000001529
Supporting passages (7)
study designPublication types: Journal Article
subjectsPURPOSE OF REVIEW: Advances in multiple sclerosis (MS) diagnosis and treatment have altered disease trajectories, yet many people with MS (pwMS) continue to experience complex symptom burden, functional limitations, and reduced quality of life (QoL).
publication datePublication date: 2026-10-27
findingsResearch evidence supports routine, multidimensional screening that goes beyond assessing symptom severity to capture functional limitations, participation restrictions, and social determinants of health (SDoH).
limitationsResearch gaps include implementation of screening pathways, optimization of person-to-treatment matching and dosing, integration of SDoH, development of meaningful patient-centred outcomes, evaluation of cost-effectiveness, and improved equity of access to rehabilitation services and research across diverse populations.
human efficacyNeurorehabilitation is a core component of comprehensive MS care, complementing pharmacological treatment.
peer reviewedPublication types: Journal Article
AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.